Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07006831 · ClinicalTrials.gov registry record
A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population
A clinical trial of Kidney Transplant and Kidney Disease, sponsored by Devyser.
- Recruiting
- Registry status
- 400
- Enrollment target
- 6
- Study locations
NCT07006831 is a study of Kidney Transplant and Kidney Disease that is actively recruiting participants, run by Devyser. The registered enrollment target is 400 participants, below the 1,885-participant average among 30 other Kidney Transplant trials with a reported enrollment target (79% lower). The trial reports 6 study locations across 5 states.
The verdict
NCT07006831, a study of Kidney Transplant and Kidney Disease, is actively recruiting participants, sponsored by Devyser.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this research is to collect blood samples and data from kidney transplant patients. The samples and data will be used for research and development of non-invasive test to detect donor-derived cell-free DNA (dd-cfDNA) in kidney transplant patients to evaluate the status of the transplanted organ.
Conditions Studied
Study Locations (6)
California
- Scripps Health - San Diego
- University of California San Francisco - San Francisco
Georgia
- Piedmont Healthcare - Atlanta
Maryland
- University of Maryland Baltimore - Baltimore
Massachusetts
- Brigham & Women's Hospital - Boston
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2025-11-14 |
| Est. Completion | 2027-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07006831
The ClinicalTrials.gov registry entry for NCT07006831 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,885-participant average among 30 other Kidney Transplant trials with a reported enrollment target (79% lower). The listed sponsor is Devyser, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Kidney Transplant appearing as the primary indexed condition, and to 0 interventions.
NCT07006831 reports 6 study locations spanning 5 distinct geographic areas - top geographies include California, Georgia, Maryland.
Frequently Asked Questions
What is clinical trial NCT07006831 about?
NCT07006831 is a clinical study titled "A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population". The purpose of this research is to collect blood samples and data from kidney transplant patients. The samples and data will be used for research and development of non-invasive test to detect donor-derived cell-free DNA (dd-cfDNA) in kidney transplant patients to evaluate the status of the transpla...
What is the current status of trial NCT07006831?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2025-11-14. Estimated completion is 2027-03.
What conditions does trial NCT07006831 study?
This clinical trial studies the following conditions: Kidney Transplant, Kidney Disease, Renal Function, Cell-free DNA, Transplant Recipient.
Who is sponsoring clinical trial NCT07006831?
This trial is sponsored by Devyser, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07006831 being conducted?
This trial has 6 study locations across California, Georgia, Maryland, Massachusetts, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
RECRUITING
-
Social Support Counseling Intervention for Kidney Transplant Candidates
RECRUITING · NA
-
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
RECRUITING · Phase 3
-
An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
RECRUITING · Phase 3
-
Advancing Transplantation Outcomes in Children
RECRUITING · Phase 2
-
Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.